Cargando…

U-500 Regular Insulin: Clinical experience and pharmacokinetics in obese, severely insulin-resistant type 2 diabetic patients

OBJECTIVE: To describe the clinical experience and the pharmacokinetics of U-500 regular insulin in severely insulin-resistant obese type 2 diabetic patients. RESEARCH DESIGN AND METHODS: Patients requiring >200 units of insulin with A1C levels >8.0% were switched to U-500 regular insulin. For...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davidson, Mayer B., Navar, Maria D., Echeverry, Diana, Duran, Petra
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2010
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2809265/ https://www.ncbi.nlm.nih.gov/pubmed/19910500 http://dx.doi.org/10.2337/dc09-1490

Ejemplares similares

Delayed Response to U-500 Regular Insulin
por: Davidson, Mayer B.
Publicado: (2018)

Pharmacokinetics and Pharmacodynamics of High-Dose Human Regular U-500 Insulin Versus Human Regular U-100 Insulin in Healthy Obese Subjects
por: de la Peña, Amparo, et al.
Publicado: (2011)

Duration and onset of action of high dose U‐500 regular insulin in severely insulin resistant subjects with type 2 diabetes
por: Shrestha, Rupendra T., et al.
Publicado: (2018)

Insulin Edema With Use of U-500 Regular Insulin in a Hybrid Closed-Loop Insulin Pump
por: Vasigh, Mostafa, et al.
Publicado: (2020)

MON-152 Less Is More: Human Regular U-500 Insulin
por: Lugo Lopez, Zahira, et al.
Publicado: (2019)

Erratum: Delayed Response to U-500 Regular Insulin. Clinical Diabetes 2018;36: 77–79 (DOI: 10.2337/cd16-0058)
por: Davidson, Mayer B.
Publicado: (2018)

FRI654 Concentrated Regular U-500 Insulin In An Automated Insulin Delivery System: A Case Report
por: Aurora, John, et al.
Publicado: (2023)

Patient-reported outcomes in transition from high-dose U-100 insulin to human regular U-500 insulin in severely insulin-resistant patients with type 2 diabetes: analysis of a randomized clinical trial
por: Kabul, Samaneh, et al.
Publicado: (2016)

Development and Implementation of a U-500 Regular Insulin Program in a Federally Qualified Health Center
por: Shaw, Kathy F., et al.
Publicado: (2017)

SAT-LB028 Efficacy and Safety of Pramlintide as an Adjunct to Insulin U500 Therapy in Veterans with Severe Insulin Resistance
por: Oprea, Mihaela, et al.
Publicado: (2019)

Advancing Patient Safety and Access to Concentrated Insulin (U-500 Regular Insulin) in the Veterans Health Administration: A Clinician Education Program in the Primary Care Setting
por: Lutz-McCain, Stacey J., et al.
Publicado: (2018)

Human regular U‐500 insulin via continuous subcutaneous insulin infusion versus multiple daily injections in adults with type 2 diabetes: The VIVID study
por: Grunberger, George, et al.
Publicado: (2020)

Initiation of human regular U-500 insulin use is associated with improved glycemic control: a real-world US cohort study
por: Eby, Elizabeth L, et al.
Publicado: (2015)

LBSUN294 Insulin-induced Abdominal Acanthosis Nigricans From High Doses Of Insulin U-500
por: Yap, Sara Elizabeth, et al.
Publicado: (2022)

Patient‐reported outcomes in a study of human regular U‐500 insulin delivered by continuous subcutaneous insulin infusion or multiple daily injections in patients with type 2 diabetes
por: Chen, Jieling, et al.
Publicado: (2020)

SAT167 Risk Of Life Threatening Hypoglycemia When Using U-100 Insulin Syringes To Administer R U-500 Insulin
por: Rizwan, Tehlil, et al.
Publicado: (2023)

Physical Activity and Insulin Resistance in 6,500 NHANES Adults: The Role of Abdominal Obesity
por: Fowler, James R., et al.
Publicado: (2020)

Comparison of Insulin Dose Adjustments by Primary Care Physicians and Endocrinologists
por: Davidson, Mayer B., et al.
Publicado: (2018)

Evaluating the Effect of U-500 Insulin Therapy on Glycemic Control in Veterans With Type 2 Diabetes
por: Granata, Joseph A., et al.
Publicado: (2015)

Pharmacokinetics and Pharmacodynamics of a Novel U500 Insulin Aspart Formulation: A Randomized, Double-Blind, Crossover Study in People With Type 1 Diabetes
por: Svehlikova, Eva, et al.
Publicado: (2023)

Human Regular 500 units/mL Insulin Therapy: A Review of Clinical Evidence and New Delivery Options
por: Sze, David, et al.
Publicado: (2018)

Insulin depot absorption modeling and pharmacokinetic simulation with insulin glargine 300 U/mL
por: Lindauer, Klaus, et al.
Publicado: (2019)

U500 Disposable Patch Insulin Pump: Results and Discussion of a Veterans Affairs Pilot Study
por: Martin, Christopher, et al.
Publicado: (2018)

Evaluation of a Conservative Pharmacist-led U-500R Insulin Management Protocol in the Primary Care Setting
por: Dumont, Cyndi, et al.
Publicado: (2020)

Lysophosphatidic Acid Signaling in Obesity and Insulin Resistance
por: D’Souza, Kenneth, et al.
Publicado: (2018)

Effect of Pharmacological Treatment of Depression on A1C and Quality of Life in Low-Income Hispanics and African Americans With Diabetes: A randomized, double-blind, placebo-controlled trial
por: Echeverry, Diana, et al.
Publicado: (2009)

Omental adipose tissue fibrosis and insulin resistance in severe obesity
por: Guglielmi, V, et al.
Publicado: (2015)

Prolonged hyperinsulinemia after subcutaneous injection of 2400 U regular insulin in a suicide attempt: Time course of serum insulin with frequent measurements
por: Hiromine, Yoshihisa, et al.
Publicado: (2012)

Obesity, Insulin Resistance, and Asthma
por: Allinson, James P., et al.
Publicado: (2022)

Correlation of insulin resistance by various methods with fasting insulin in obese
por: Panag, Kanwal Mohinder Dev Singh, et al.
Publicado: (2014)

Glargine insulin: an alternative to regular insulin for glycemic control in critically ill patients
por: Bhattacharyya, M, et al.
Publicado: (2007)

OR30-02 Efficacy and Safety Comparison Between U100 Regular Human Insulin and U100 Rapid Acting Insulin When Delivered by a 24 Hour Wearable Insulin Delivery Device in Type 2 Diabetes
por: Mora, Pablo, et al.
Publicado: (2020)

Insulin Therapy: A Personal Approach
por: Davidson, Mayer B.
Publicado: (2015)

Insulin Resistance Predicts Mortality in Nondiabetic Individuals in the U.S.
por: Ausk, Karlee J., et al.
Publicado: (2010)

Fitness versus Fatness and Insulin Resistance in U.S. Adolescents
por: Cummings, Doyle M., et al.
Publicado: (2010)

Obesity and Insulin Resistance: An Ongoing Saga
por: Kim, Sun H., et al.
Publicado: (2010)

Obesity, Insulin Resistance and Cancer Risk
por: Jee, Sun Ha, et al.
Publicado: (2005)

MicroRNAs in Insulin Resistance and Obesity
por: Williams, Michael D., et al.
Publicado: (2012)

Prevalence of insulin resistance in obese adolescence
por: Puspitadewi, Ardita, et al.
Publicado: (2013)

Vascular stiffness in insulin resistance and obesity
por: Jia, Guanghong, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ds74eaievdbbc1jrteisu1sb47